Turner NC, Swift C, Jenkins B, Kilburn L, et al. Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate and high-risk early stage triple negative breast cancer. Ann Oncol 2022 Nov 21:S0923-7534(22)04735-4. doi: 10.1016/j.annonc.2022.
PMID: 36423745